Entrada Therapeutics (TRDA) Earnings Date & Reports
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TRDA is expected to report earnings to fall 3.77% to -101 cents per share on March 18
Q4'25
Est.
$-1.02
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
Q4'24
Beat
by $0.70
The last earnings report on November 06 showed earnings per share of -105 cents, missing the estimate of -99 cents. With 388.28K shares outstanding, the current market capitalization sits at 306.52M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on November 06, 2025. You can read more about the earnings report here.